| Peer-Reviewed

Pityriasis Rosea Gibert - Disease History and New Findings

Received: 30 May 2022    Accepted: 20 June 2022    Published: 30 June 2022
Views:       Downloads:
Abstract

The author's aim in this article is to describe a common exanthematic disease typical of adolescence, pityriasis rosea Gibert, in the light of new findings. Another aim is to draw attention to an overlooked fact about the difficulty and inconsistency of therapy with the recommended course of action. The author uses his own experience from his many years of dermatological practice and adds facts from current literature sources on the disease. The meaning of the disease name is explained and the historical implications of the disease name are clarified. The current view of its probable viral etiopathogenesis and its similarity to another exanthematous skin disease, exanthema subitum, are described. The prodromal stage of the disease and the clinical picture of the skin findings with characteristic seeding of lesions resembling "Christmas tree branches" are described. The author's clinical pictures of the findings in individual patients with this disease are included. The possible relationship with COVID-19 is noted. The differential diagnosis is discussed, including the similarity to secondary syphilis, and the uncharacteristic histopathological picture of the disease is described. Finally, treatment options are discussed, with the caveat that the very common use of topical corticosteroids is not very effective and rather non-corticoid external therapy is recommended. The author draws attention to the possible alteration of the psychological state of predominantly adolescent patients due to the frequent long persistence of cutaneous, and therefore visible, symptoms.

Published in Pathology and Laboratory Medicine (Volume 6, Issue 1)
DOI 10.11648/j.plm.20220601.12
Page(s) 7-10
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Pityriasis Rosea, HHV-6, HHV-7

References
[1] BRAUN-FALCO, O., PLEWIG, G., WOLF, H. (2001). Dermatológia a venerológia, Osveta, s.r.o., Martin, 2001, 486–488.
[2] DANDA, V. et al. (1979). Vybrané kapitoly z dermatovenerologie, Hradec Králové: VLVDÚ 1979, 121.
[3] BAKER, H. (1989). Clinical dermatology, fourth edition, London: Bailliere Tindall 1989, 48–49.
[4] ŠTORK, J. et al. (2008). Dermatovenerologie, Praha Galén, 2008, 176–177.
[5] FADRHONCOVÁ, A. (1999). Farmakoterapie kožních nemocí, Praha: Grada 1999, 363–364.
[6] HERCOGOVÁ, J. (2019). Klinická dermatovenerologie, Praha: Mladá fronta 2019, 294-295.
[7] NENEMAN, A. (2017). Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C virus. Postepy Dermatol Alergol. 2017 Jun; 34 (3): 276–278.
[8] VERALDI, S., ROMAGNUOLO, M., BENZECRY, V. (2020). Pityriasis rosea-like eruption revealing COVID-19. Australas J Dermatol. 2020 Nov 20: 10.1111/ajd.13504.
[9] FITZPATRICK, T. (1983). Color atlas and synopsys of clinical dermatilogy, The McGraw-Hill Companies, 3rd edition, 1983, 104-105.
[10] BENAKOVA N. et al. (2020). Moderní terapie v dermatologii, Praha: Maxdorf 2020, 143.
[11] LEENUTAPHONG, V., JIAMTON, S. (1995). UVB phototherapy for pityriasis rosea: a bilateral comparison study. J Am Acad Dermatol. 1995; 33: 996–9.
[12] DRAGO, F., VECCHIO, F., REBORA, A. (2006). Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006; 54: 82–5.
[13] SHARMA, PK., YADAV TP., GAUTAM RK. et al. (2000). Erythromycin in pityriasis rosea: a double-blind, placebo-controlled clinical trial. J Am Acad Dermatol. 2000; 42: 241– 4.
[14] BENAKOVA N. et al. (2013). Ekzémy a dermatitidy, 3rd edition Praha: Maxdorf 2013, 55.
[15] SUCHOPÁR J. (1999). Remedia compendium, 3rd edition, Praha: Panax 1999, 645.
Cite This Article
  • APA Style

    Konrad Pavel. (2022). Pityriasis Rosea Gibert - Disease History and New Findings. Pathology and Laboratory Medicine, 6(1), 7-10. https://doi.org/10.11648/j.plm.20220601.12

    Copy | Download

    ACS Style

    Konrad Pavel. Pityriasis Rosea Gibert - Disease History and New Findings. Pathol. Lab. Med. 2022, 6(1), 7-10. doi: 10.11648/j.plm.20220601.12

    Copy | Download

    AMA Style

    Konrad Pavel. Pityriasis Rosea Gibert - Disease History and New Findings. Pathol Lab Med. 2022;6(1):7-10. doi: 10.11648/j.plm.20220601.12

    Copy | Download

  • @article{10.11648/j.plm.20220601.12,
      author = {Konrad Pavel},
      title = {Pityriasis Rosea Gibert - Disease History and New Findings},
      journal = {Pathology and Laboratory Medicine},
      volume = {6},
      number = {1},
      pages = {7-10},
      doi = {10.11648/j.plm.20220601.12},
      url = {https://doi.org/10.11648/j.plm.20220601.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.plm.20220601.12},
      abstract = {The author's aim in this article is to describe a common exanthematic disease typical of adolescence, pityriasis rosea Gibert, in the light of new findings. Another aim is to draw attention to an overlooked fact about the difficulty and inconsistency of therapy with the recommended course of action. The author uses his own experience from his many years of dermatological practice and adds facts from current literature sources on the disease. The meaning of the disease name is explained and the historical implications of the disease name are clarified. The current view of its probable viral etiopathogenesis and its similarity to another exanthematous skin disease, exanthema subitum, are described. The prodromal stage of the disease and the clinical picture of the skin findings with characteristic seeding of lesions resembling "Christmas tree branches" are described. The author's clinical pictures of the findings in individual patients with this disease are included. The possible relationship with COVID-19 is noted. The differential diagnosis is discussed, including the similarity to secondary syphilis, and the uncharacteristic histopathological picture of the disease is described. Finally, treatment options are discussed, with the caveat that the very common use of topical corticosteroids is not very effective and rather non-corticoid external therapy is recommended. The author draws attention to the possible alteration of the psychological state of predominantly adolescent patients due to the frequent long persistence of cutaneous, and therefore visible, symptoms.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Pityriasis Rosea Gibert - Disease History and New Findings
    AU  - Konrad Pavel
    Y1  - 2022/06/30
    PY  - 2022
    N1  - https://doi.org/10.11648/j.plm.20220601.12
    DO  - 10.11648/j.plm.20220601.12
    T2  - Pathology and Laboratory Medicine
    JF  - Pathology and Laboratory Medicine
    JO  - Pathology and Laboratory Medicine
    SP  - 7
    EP  - 10
    PB  - Science Publishing Group
    SN  - 2640-4478
    UR  - https://doi.org/10.11648/j.plm.20220601.12
    AB  - The author's aim in this article is to describe a common exanthematic disease typical of adolescence, pityriasis rosea Gibert, in the light of new findings. Another aim is to draw attention to an overlooked fact about the difficulty and inconsistency of therapy with the recommended course of action. The author uses his own experience from his many years of dermatological practice and adds facts from current literature sources on the disease. The meaning of the disease name is explained and the historical implications of the disease name are clarified. The current view of its probable viral etiopathogenesis and its similarity to another exanthematous skin disease, exanthema subitum, are described. The prodromal stage of the disease and the clinical picture of the skin findings with characteristic seeding of lesions resembling "Christmas tree branches" are described. The author's clinical pictures of the findings in individual patients with this disease are included. The possible relationship with COVID-19 is noted. The differential diagnosis is discussed, including the similarity to secondary syphilis, and the uncharacteristic histopathological picture of the disease is described. Finally, treatment options are discussed, with the caveat that the very common use of topical corticosteroids is not very effective and rather non-corticoid external therapy is recommended. The author draws attention to the possible alteration of the psychological state of predominantly adolescent patients due to the frequent long persistence of cutaneous, and therefore visible, symptoms.
    VL  - 6
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Dermatology Clinic Lasermed, Praque, Czech Republic

  • Sections